Sanmai sits in the focused ultrasound neuromodulation segment, with Lotus positioned around AI-supported acoustic targeting for psychiatric and neurological indications. Its strategic relevance comes from applying tFUS to mental health, where the established non-invasive stimulation landscape is still largely shaped by TMS and electrical stimulation.